Condition
Anatomic Stage IIIC Breast Cancer AJCC v8
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 69 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownTesting Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialNCT07391774 · 2026-08-10
RECRUITINGPersonalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast CancerNCT06324240 · 2025-12-02
RECRUITINGTopical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast CancerNCT05417308 · 2023-03-01
RECRUITINGPhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxNCT05092373 · 2022-04-29
RECRUITINGPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsNCT05269381 · 2022-03-31
RECRUITINGOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerNCT04090567 · 2020-07-28
RECRUITINGDecision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast CancerNCT02918474 · 2017-04-28
RECRUITINGSTEMVAC in Patients With Early Stage Triple Negative Breast CancerNCT05455658 · 2022-11-17
ACTIVE_NOT_RECRUITINGHealth Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer SurvivorsNCT05674578 · 2022-11-14
COMPLETEDTranscutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast CancerNCT05368428 · 2022-10-19
TERMINATEDEffects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast CancerNCT05244434 · 2022-07-03
WITHDRAWNDiabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer SurvivorsNCT04560439 · 2022-06-15
WITHDRAWNA Quality of Life Intervention for Young African American Breast Cancer Survivors in TreatmentNCT05243056 · 2022-06-01
TERMINATEDPiloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer SurvivorsNCT05452681 · 2022-06-01
TERMINATEDRibociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast CancerNCT05319873 · 2022-04-07
ACTIVE_NOT_RECRUITINGPanitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast CancerNCT05177796 · 2022-03-11
WITHDRAWNSocial Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsNCT07259304 · 2021-11-24
ACTIVE_NOT_RECRUITINGAn Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer SurvivorsNCT05012176 · 2021-11-01
COMPLETEDMobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast CancerNCT05086731 · 2021-10-22
COMPLETEDSafely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving PaclitaxelNCT04862585 · 2021-10-07
COMPLETEDCulturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal StudyNCT04754412 · 2021-07-23
ACTIVE_NOT_RECRUITINGWeb-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer SurvivorsNCT04906200 · 2021-06-28
ACTIVE_NOT_RECRUITINGTreatment Decision Making in African American Women Diagnosed With Triple Negative Breast CancerNCT05071677 · 2021-05-03
COMPLETEDCognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNCT04705025 · 2021-04-08
TERMINATEDMultiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer SurvivorsNCT04999826 · 2021-04-01
COMPLETEDAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerNCT04498520 · 2021-03-31
WITHDRAWNImproving Patient-Centered Communication in Breast Cancer Through Patient and Provider InterventionsNCT04549571 · 2021-02-16
ACTIVE_NOT_RECRUITINGHealth Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyNCT04927559 · 2020-12-18
TERMINATEDNilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast CancerNCT04205903 · 2020-12-11
COMPLETEDNipple Aspirate Fluid in Detecting Breast CancerNCT03715959 · 2020-12-10
COMPLETEDExercise During Chemotherapy in Older Women With Stage I-III Breast CancerNCT05025059 · 2020-12-03
ACTIVE_NOT_RECRUITINGLorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast CancerNCT04205071 · 2020-11-01
WITHDRAWNPlatelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast CancerNCT04535323 · 2020-09-23
COMPLETEDRifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast CancerNCT04249622 · 2020-09-18
TERMINATEDRBX7455 Before Surgery for the Treatment of Operable Breast CancerNCT04139993 · 2020-08-31
TERMINATEDNab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN AlterationsNCT04216472 · 2020-07-10
TERMINATEDImpact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and HandNCT04876378 · 2020-05-18
TERMINATEDAnastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast CancerNCT04294225 · 2020-04-28
COMPLETEDTai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint TrialNCT04716920 · 2020-03-11
COMPLETEDLifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer SurvivorsNCT04200482 · 2020-02-21
COMPLETEDT-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast CancerNCT03554044 · 2020-02-05
COMPLETEDCryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast CancerNCT04249167 · 2020-01-23
WITHDRAWNAtorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant ChemotherapyNCT03872388 · 2019-09-23
TERMINATEDDocetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerNCT04001829 · 2019-08-09
ACTIVE_NOT_RECRUITINGGenetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyNCT03707574 · 2019-07-16
COMPLETEDAlpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast CancerNCT03207529 · 2019-06-07
COMPLETEDPharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerNCT04067960 · 2019-06-06
COMPLETEDTreatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerNCT03939481 · 2019-05-14
ACTIVE_NOT_RECRUITINGInfertility Survey Among Reproductive Age Women With Gynecological and Breast CancerNCT04678414 · 2019-04-01
ACTIVE_NOT_RECRUITINGExercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer SurvivorsNCT03751449 · 2019-03-25
TERMINATEDExercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer SurvivorsNCT04454086 · 2019-03-06
COMPLETEDALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsNCT03725436 · 2019-01-24
COMPLETEDIntensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast CancerNCT03786354 · 2019-01-09
ACTIVE_NOT_RECRUITINGA Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast CancerNCT04086875 · 2018-11-07
UNKNOWNPI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryNCT03218826 · 2018-09-24
COMPLETEDCarbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal AtrophyNCT03666819 · 2018-09-10
WITHDRAWNHydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast CancerNCT03774472 · 2018-08-20
COMPLETEDAcupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast CancerNCT03505671 · 2018-08-03
COMPLETEDM7824 in Treating Patients With Stage II-III HER2 Positive Breast CancerNCT03620201 · 2018-08-03
COMPLETEDStress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast CancerNCT03505736 · 2018-06-21
COMPLETEDCommon interventions
Questionnaire AdministrationOTHER28Quality-of-Life AssessmentOTHER23Best PracticeOTHER10Biospecimen CollectionPROCEDURE8Survey AdministrationOTHER7PaclitaxelDRUG6InterviewOTHER4LetrozoleDRUG4PembrolizumabBIOLOGICAL4AnastrozoleDRUG3BiopsyPROCEDURE3CarboplatinDRUG3CyclophosphamideDRUG3DocetaxelDRUG3Educational InterventionOTHER3FulvestrantDRUG3Informational InterventionOTHER3Laboratory Biomarker AnalysisOTHER3Magnetic Resonance ImagingPROCEDURE3Medical Device Usage and EvaluationOTHER3Nab-paclitaxelDRUG3AlpelisibDRUG2CapecitabineDRUG2ChemotherapyDRUG2Computed TomographyPROCEDURE2
Leading sponsors
M.D. Anderson Cancer Center
21
Ohio State University Comprehensive Cancer Center
10
Mayo Clinic
9
Emory University
3
Fred Hutchinson Cancer Center
3
National Cancer Institute (NCI)
3
City of Hope Medical Center
2
Jonsson Comprehensive Cancer Center
2
Thomas Jefferson University
2
University of Alabama at Birmingham
2
University of California, San Francisco
2
University of Southern California
2
Wake Forest University Health Sciences
2
Alliance for Clinical Trials in Oncology
1
ECOG-ACRIN Cancer Research Group
1
Trial status mix
COMPLETED29
ACTIVE_NOT_RECRUITING14
TERMINATED11
RECRUITING7
WITHDRAWN7
UNKNOWN1
Phase mix
NA24
PHASE117
PHASE217
EARLY_PHASE14
PHASE32
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.